Introducing the Molecular Pharmaceutics Special Issue on Industrial Drug Delivery─In Silico to Bedside
Mol Pharm
.
2023 Oct 2;20(10):4797-4799.
doi: 10.1021/acs.molpharmaceut.3c00831.
Authors
Liping Zhou
1
,
Annette Bak
1
,
Kenji Hyodo
2
,
Bertil Abrahamsson
3
Affiliations
1
Advanced Drug Delivery, Pharmaceutical Science, BioPharmaceutical R&D, AstraZeneca Boston, Waltham, Massachusetts 02451, United States.
2
Advanced Drug Delivery, Emerging Modality Generation Department, Discovery Evidence Generation Function, Deep Human Biology Learning, Eisai Co., Ltd., Tokyo 112-8088, Japan.
3
Oral Product Development, Pharmaceutical Technology Development, Operations, AstraZeneca Gothenburg, 431 50 Mölndal, Sweden.
PMID:
37779466
DOI:
10.1021/acs.molpharmaceut.3c00831
No abstract available
Publication types
Editorial
MeSH terms
Biopharmaceutics*
Chemistry, Pharmaceutical
Drug Delivery Systems
Pharmacy*